In a smart, recent approach, the administration of key protease inhibitors successfully stabilized des-(Glu)5-gastrin radioligands in vivo, significantly enhancing CCK2R-positive tumor uptake in mice and MTC patients [15,16]. The gene discussed is CCKBR; the disease is medullary thyroid gland carcinoma.